Two rare mutations in Turkey: IVS I.130(G-C) and IVS II.848(C-A)

Clin Lab Haematol. 2005 Aug;27(4):274-7. doi: 10.1111/j.1365-2257.2005.00691.x.

Abstract

Beta-thalassemia, an autosomal recessive disease, results from mutations of the beta-globin gene. More than 40 different mutations found in Turkish beta-thalassemia patients are mostly composed of point mutations, and only in very rare cases a deletion or an insertion causes beta-thalassemia phenotypes. Here, we report two patients who were clinically diagnosed with beta-thalassemia major and HbS/beta-thalassemia respectively. We performed reverse dot blot hybridization method and automated sequence analysis to detect the mutations. One of the patients was found to be IVS I.130 (G-C) homozygous, the other was HbS/IVS II.848 (C-A) as compound heterozygous. The aim of this study was to report hematological and clinical findings in both cases related with beta-globin gene defects that are very rare.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • DNA / analysis
  • DNA / isolation & purification
  • Hemoglobin, Sickle / genetics*
  • Humans
  • Male
  • Point Mutation*
  • Sequence Analysis, DNA / methods*
  • Turkey / epidemiology
  • beta-Thalassemia / diagnosis
  • beta-Thalassemia / genetics*

Substances

  • Hemoglobin, Sickle
  • DNA